Document Detail


Correlation of serum hormone concentrations in maternal and umbilical cord samples.
MedLine Citation:
PMID:  12750241     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Evidence suggests that adult cancer risk of hormonally related tumors may be influenced by the in utero environment, and most speculation on the biological mechanism has focused on the hormonal component. Epidemiological studies investigating the biological nature of pregnancy and maternal factors associated with offspring's cancer risk have relied on maternal hormone measurements. The degree to which maternal hormone levels represent the fetal environment, however, is not widely known. Pregnancy estrogen, androstenedione, testosterone, dehydroepiandrosterone (DHEA), and DHEA-sulfate concentrations were measured in maternal and mixed umbilical cord sera from 86 singleton pregnancies. Spearman correlations between maternal and cord hormone levels generally ranged between 0.2 and 0.3. The correlation was 0.26 for estriol, the estrogen of highest concentration in pregnancy, and 0.27 for estradiol, the most biologically active estrogen. The correlations between mother and offspring for the estrogens and DHEA appeared similar for males and females, whereas there was a suggestion that the maternal-umbilical cord correlations for other androgens varied in magnitude by fetal sex, and all correlations appeared higher in pregnancies lasting <38 weeks compared with longer gestational lengths, although these stratified findings may have been attributable to chance. These data show a moderate degree of correlation in hormone concentrations between the maternal and fetal circulation. Studies using maternal hormone concentrations as a proxy for the fetal environment should consider the misclassification resulting with the use of this marker.
Authors:
Rebecca Troisi; Nancy Potischman; James M Roberts; Gail Harger; Nina Markovic; Bernard Cole; David Lykins; Pentti Siiteri; Robert N Hoover
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology     Volume:  12     ISSN:  1055-9965     ISO Abbreviation:  Cancer Epidemiol. Biomarkers Prev.     Publication Date:  2003 May 
Date Detail:
Created Date:  2003-05-16     Completed Date:  2003-09-12     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9200608     Medline TA:  Cancer Epidemiol Biomarkers Prev     Country:  United States    
Other Details:
Languages:  eng     Pagination:  452-6     Citation Subset:  IM    
Affiliation:
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland 20892, USA. troisir@mail.nih.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Androstenedione / blood
Biological Markers / blood
Case-Control Studies
Dehydroepiandrosterone / blood
Dehydroepiandrosterone Sulfate / blood
Estradiol / blood
Estriol / blood
Estrone / blood
Female
Fetal Blood
Hormones / blood*
Humans
Infant, Newborn
Male
Neoplasms / epidemiology,  etiology
Pennsylvania / epidemiology
Pregnancy / blood*
Testosterone / blood
Grant Support
ID/Acronym/Agency:
2 P01 HD30367/HD/NICHD NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 0/Hormones; 50-27-1/Estriol; 50-28-2/Estradiol; 53-16-7/Estrone; 53-43-0/Dehydroepiandrosterone; 58-22-0/Testosterone; 63-05-8/Androstenedione; 651-48-9/Dehydroepiandrosterone Sulfate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Antibodies against 5-hydroxymethyl-2'-deoxyuridine are associated with lifestyle factors and GSTM1 g...
Next Document:  Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382...